Early enzyme replacement therapy prevents dental and craniofacial abnormalities in a mouse model of mucopolysaccharidosis type VI

Mucopolysaccharidosis VI (MPS VI) is a hereditary lysosomal storage disease caused by the absence of the enzyme arylsulfatase B (ARSB). Craniofacial defects are common in MPS VI patients and manifest as abnormalities of the facial bones, teeth, and temporomandibular joints. Although enzyme replaceme...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagpal, Rohit, Georgi, Gina, Knauth, Sarah, Schmid-Herrmann, Carmen, Muschol, Nicole, Braulke, Thomas, Kahl-Nieke, Bärbel, Amling, Michael, Schinke, Thorsten, Koehne, Till, Petersen, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532570/
https://www.ncbi.nlm.nih.gov/pubmed/36213247
http://dx.doi.org/10.3389/fphys.2022.998039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532570/
https://www.ncbi.nlm.nih.gov/pubmed/36213247
http://dx.doi.org/10.3389/fphys.2022.998039

Ejemplares similares